Alcon price target raised to $104 from $95 at Baird

Baird analyst Jeff Johnson raised the firm’s price target on Alcon to $104 from $95 and keeps an Outperform rating on the shares. The firm said the company’s market leadership in diverse, solid growth markets was on full display in 1Q-24 and with contact lens revenue/margins increasingly driving 2024 and surgical set to drive 2025, Baird continues to like the multi-year set-up on this name.